LifeStance Health Group Inc
Research LifeStance Health Group Inc (LFST) on Bullrun: valuation model: 43.0% overvalued, market cap USD 4.69B, P/E 94.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLFST
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Valuation signal43.0% overvalued
- Market capUSD 4.69B
- P/E94.5
- Financial periodQ2 2026
- RevenueUSD 435.35M
- Net incomeUSD 23.61M
- Free cash flowUSD 87.92M
- Gross margin35.2%
Valuation Snapshot
Bullrun's latest valuation model marks LifeStance Health Group Inc as 43.0% overvalued; latest market cap is USD 4.69B; P/E is 94.5.
Peer valuation comparison
Latest P/E is 94.46x versus a Healthcare sector median of 24.46x (286.2% above).
Latest P/E is 94.46x versus a United States median of 24.87x (279.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.42B | USD 9.66M | USD 110.03M | 32.4% | 0.01 | USD 248.64M | USD 280.43M | USD 1.52B |
| FY2024 | USD 1.25B | -USD 57.44M | USD 85.69M | 32.2% | n/a | USD 154.57M | USD 287.04M | USD 1.45B |
| FY2023 | USD 1.06B | -USD 186.26M | -USD 57.40M | n/a | -0.9 | USD 78.82M | USD 283.21M | USD 1.43B |
| FY2022 | USD 859.54M | -USD 215.56M | -USD 26.47M | n/a | n/a | USD 108.62M | USD 227.42M | USD 1.52B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.69B | 94.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.73B | 234.7 | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.82B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.96B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.86B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.56B | n/a | n/a | n/a |
About LifeStance Health Group Inc
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is LifeStance Health Group Inc overvalued or undervalued?
Bullrun's valuation model currently marks LifeStance Health Group Inc as 43.0% overvalued.
What is LifeStance Health Group Inc's market cap?
LifeStance Health Group Inc's market capitalization is USD 4.69B.
What is LifeStance Health Group Inc's P/E ratio?
LifeStance Health Group Inc's price-to-earnings (P/E) ratio is 94.5.
What does LifeStance Health Group Inc do?
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.